Cindy received a BS in Mathematics in 1993 from East Carolina University in North Carolina, USA. In 2001 she completed an MPH in Biostatistics from the University of North Carolina at Chapel Hill in North Carolina, USA. Started her career in the pharmaceutical industry in 1993 working with statistical process control as a quality assurance auditor at Burroughs Wellcome and managing product stability studies a Magellan Laboratories and Bayer Biologics. After completing graduate studies in biostatistics, Cindy worked as a senior Biostatistician at Quintiles, Inc. She moved to Schwarz Biosciences in 2005 which became UCB Biosciences in 2008. At UCB Cindy has held different roles within clinical development late phase biostatistics. These include senior biostatistician, principal biostatistician, associate director/US group head, and Mission Lead within the neurology therapeutic area. Cindy is currently a director of biostatistics, serving as the Safety Statistics lead within the Statistical Science and Innovations group at UCB.